Genentech's second phase III study of Lucentis in diabetic macular edema meets primary endpoint March 28, 2011 No Comments
Omeros' phase IIb study of OMS-302 meets coprimary endpoints in cataract surgery March 25, 2011 No Comments
Phase I/II results for InSite Vision's ISV-303 encouraging for cataract postsurgery pain March 24, 2011 No Comments
FDA approves IND for StarGen, a novel ocular product for Stargardt's disease March 22, 2011 No Comments
Quark terminates phase II study of PF-04523655 early, plans phase IIb study March 21, 2011 No Comments
FDA accepts Merck & Co.'s tafluprost NDA to treat elevated intraocular pressure March 11, 2011 No Comments
Aerie Pharma secures financing to support advancement of glaucoma portfolio March 11, 2011 No Comments
RSS